Patents/Inventors

Nan Ji

Hong KongCN50 patents

28 Patents

US125993362026
Wearable Apparatus for Continuous Monitoring of Physiological Parameters
0 cites
US125996722026
KRAS Proteolysis Targeting Chimeras
PAQ Therapeutics Inc.
0 cites
US125939912026
Method and a Device for Calibrating a Blood Pressure Estimation Model for Determining Tonoarteriogram Signals
0 cites
US125584272026
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125456592026
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125401272026
CRBN Ligands and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125287852026
MDM2 Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125274802026
Method, a Device, an Electronic Apparatus and a Storage Medium for Processing Multi-modal Physiological Signals
0 cites
US124545202025
Protein Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US124042852025
KRAS G12D Proteolysis Targeting Chimeras
PAQ Therapeutics Inc.
0 cites
US123768032025
Method and Apparatus for Heart-level Blood Pressure Estimation Based on Ensemble Learning
0 cites
US123782002025
Oxopyridine Derivatives Useful as Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors
Orsobio, Inc.
0 cites
US123644022025
Multi-modal Sensor Module and a Multi-modal Physiological Signal Monitoring System
Hong Centre For Cerebro-cardiovascular Health Engineering Limited
0 cites
US122583412025
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US121680572024
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US121509952024
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US120775552024
STAT Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US120063292024
Protein Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US119935852024
Poly-adp Ribose Polymerase (PARP) Inhibitors
Mitobridge, Inc.
0 cites
US119637822024
Method and Apparatus of Analyzing the ECG Frequency Parameters for the Diagnosis of STEMI Diseases
0 cites
US119326242024
MDM2 Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US119326352024
CRBN Ligands and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US118978822024
Tricyclic Crbn Ligands and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US118076362023
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US117808122023
Oxopyridine Derivatives Useful as Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors
Orsobio, Inc.
0 cites
US117461202023
Stat Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US117239802023
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US116239322023
Protein Degraders and Uses Thereof
KYMERA THERAPEUTICS, Inc.
0 cites